ALKS vs WAT · P/E 14, rev $1.56B vs P/E 32, rev $1.65B
Alkermes Plc (ALKS) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the ALKS and WAT stock pages for the full models.
Not investment advice.